FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

1918111000001107: ReQuip 250microgram tablets (GlaxoSmithKline) 210 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25459901000001110 ReQuip 250microgram tablets (GlaxoSmithKline) 210 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
58165101000001118 ReQuip 250microgram tablets (GlaxoSmithKline UK Ltd) 210 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
ReQuip 250microgram tablets (GlaxoSmithKline) 210 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline) 210 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline) 210 tablet Is a Ropinirole 250microgram tablets 210 tablet true Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline) 210 tablet Is pack of ReQuip 250microgram tablets (GlaxoSmithKline) false Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline) 210 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline) 210 tablet Has active ingredient Ropinirole hydrochloride false Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline) 210 tablet Has active ingredient Ropinirole false Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline) 210 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline) 210 tablet Has excipient Polysorbate false Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline) 210 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline) 210 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline) 210 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline) 210 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline) 210 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline) 210 tablet Has AMP ReQuip 250microgram tablets (GlaxoSmithKline) true Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline) 210 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ropinirole true Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline) 210 tablet Has specific active ingredient Ropinirole hydrochloride true Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline) 210 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline) 210 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline) 210 tablet Has basis of strength substance Ropinirole true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start